[HTML][HTML] Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad
The pathogenesis of Coronavirus disease 2019 (COVID-19) is gradually being
comprehended. A high number of thrombotic episodes are reported, along with the mortality …
comprehended. A high number of thrombotic episodes are reported, along with the mortality …
Coronavirus disease 2019–associated coagulopathy
Patients with the severe form of coronavirus disease 2019 (COVID-19) have been frequently
found to suffer from both arterial and venous thrombotic events due to the perpetuation of a …
found to suffer from both arterial and venous thrombotic events due to the perpetuation of a …
SARS-CoV-2 and coagulation disorders in different organs
S Vinayagam, K Sattu - Life sciences, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) is a prominent pandemic disease that
emerged in China and hurriedly stretched worldwide. There are many reports on COVID-19 …
emerged in China and hurriedly stretched worldwide. There are many reports on COVID-19 …
Thrombosis and coagulopathy in COVID‐19: an illustrated review
M Levi, BJ Hunt - Research and practice in thrombosis and …, 2020 - Wiley Online Library
This illustrated review discusses the haemostatic changes seen in patients with severe
coronavirus disease 2019 (COVID‐19) infection and their possible causes. We discuss the …
coronavirus disease 2019 (COVID‐19) infection and their possible causes. We discuss the …
[HTML][HTML] Coagulopathy in COVID‐19
The COVID‐19 pandemic has become an urgent issue in every country. Based on recent
reports, the most severely ill patients present with coagulopathy, and disseminated …
reports, the most severely ill patients present with coagulopathy, and disseminated …
[HTML][HTML] The coagulopathy, endotheliopathy, and vasculitis of COVID-19
Abstract Background COVID-19-associated coagulopathy (CAC) characterized by the
elevated D-dimer without remarkable changes of other global coagulation markers is …
elevated D-dimer without remarkable changes of other global coagulation markers is …
[HTML][HTML] Coagulopathy in COVID-19 and its implication for safe and efficacious thromboprophylaxis
F Langer, S Kluge, R Klamroth… - Hämostaseologie, 2020 - thieme-connect.com
The novel coronavirus, SARS-CoV-2, is causing a global pandemic of life-threatening
multiorgan disease, called COVID-19. Accumulating evidence indicates that patients with …
multiorgan disease, called COVID-19. Accumulating evidence indicates that patients with …
[HTML][HTML] Thrombotic complications in patients with COVID-19: pathophysiological mechanisms, diagnosis, and treatment
A Gąsecka, JA Borovac, RA Guerreiro… - … drugs and therapy, 2021 - Springer
Introduction Emerging evidence points to an association between severe clinical
presentation of COVID-19 and increased risk of thromboembolism. One-third of patients …
presentation of COVID-19 and increased risk of thromboembolism. One-third of patients …
Clinical features of thrombosis and bleeding in COVID-19
MR Thomas, M Scully - Blood, The Journal of the American …, 2022 - ashpublications.org
Infection with the SARS-CoV-2 virus, resulting in COVID-19 disease, has presented a
unique scenario associated with high rates of thrombosis. The risk of venous thrombosis is …
unique scenario associated with high rates of thrombosis. The risk of venous thrombosis is …
[HTML][HTML] COVID‐19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance
SC Cannegieter, FA Klok - Research and Practice in Thrombosis …, 2020 - ncbi.nlm.nih.gov
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative
pathogen of a new infectious disease, coronavirus disease 2019 (COVID-19), that first …
pathogen of a new infectious disease, coronavirus disease 2019 (COVID-19), that first …